Cambridge Investment Research Advisors’s Amalgamated Financial AMAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$440K Buy
11,330
+4
+0% +$152 ﹤0.01% 2917
2025
Q4
$363K Buy
11,326
+3
+0% +$87 ﹤0.01% 3011
2025
Q3
$307K Hold
11,323
﹤0.01% 3091
2025
Q2
$353K Hold
11,323
﹤0.01% 2847
2025
Q1
$326K Hold
11,323
﹤0.01% 2782
2024
Q4
$379K Sell
11,323
-58
-0.5% -$1.99K ﹤0.01% 2647
2024
Q3
$357K Buy
11,381
+168
+1% +$5.09K ﹤0.01% 2692
2024
Q2
$307K Buy
11,213
+2,231
+25% +$54.5K ﹤0.01% 2686
2024
Q1
$216K Buy
+8,982
New +$221K ﹤0.01% 2968

Other funds holding AMAL

Cambridge Investment Research Advisors's AMAL Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its Amalgamated Financial (AMAL) stake by 0.04% in Q1 2026, buying an estimated $152 and bringing the position to 11,330 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #2917.

Cambridge Investment Research Advisors first reported a position in AMAL in Q1 2024 and has held it in 9 quarters since. 176 funds tracked by Wall St. Rank hold AMAL as of Q1 2026.

  • Cambridge Investment Research Advisors held 11,330 shares of Amalgamated Financial worth $440K as of Q1 2026.
  • Cambridge Investment Research Advisors bought 4 Amalgamated Financial shares in Q1 2026, an estimated $152.
  • Amalgamated Financial made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #2917 holding.
  • Cambridge Investment Research Advisors first reported a position in Amalgamated Financial in Q1 2024 and has held it in 9 quarters since.
  • 176 funds tracked by Wall St. Rank held Amalgamated Financial as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.